<DOC>
	<DOCNO>NCT02965768</DOCNO>
	<brief_summary>The main objective study test naltrexone , take low dos , anti-inflammatory effect may associate positive clinical outcome people chronic fatigue syndrome ( CFS ) . In part , present study , continuation prior work show chronic fatigue symptom associate immune activity , low-dose naltrexone might exert anti-inflammatory effect fibromyalgia , think share pathophysiological clinical characteristic CFS .</brief_summary>
	<brief_title>Immune Effects Low-dose Naltrexone ME/CFS</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Fatigue</mesh_term>
	<mesh_term>Fatigue Syndrome , Chronic</mesh_term>
	<mesh_term>Naltrexone</mesh_term>
	<criteria>1 . Meet 1994 Case Definition criterion CFS ( assess semistructured interview DePaul University Fatigue Questionnaire ) : Criteria : Severe chronic fatigue ≥6 consecutive month due ongoing exertion medical condition associate fatigue ; Fatigue interfere daily activity work ; Reports ≥4 symptom start fatigue , : Postexertion malaise &gt; 24 hour Unrefreshing sleep Shortterm memory concentration impairment Muscle pain Joint pain without swell redness Headaches new type/pattern/severity Lymph node tenderness Frequent recur sore throat 3 . CFS symptom ≥12 month 4 . Participant completes daily selfreport 4week baseline period ; 5 . Able attend UAB schedule appointment 1 . Blood draw contraindicate otherwise able perform 2 . Highsensitivity creactive protein ( HSCRP ) ≥3 mg/L 3 . Erythrocyte sedimentation rate ( ESR ) &gt; 60 mm/hr 4 . Positive rheumatoid factor 5 . Positive antinuclear antibody ( ANA ) 6 . Levels thyroid stimulate hormone free thyroxine outside UAB lab reference value 7 . Diagnosed rheumatological autoimmune condition 8 . Clotting disorder 9 . Use blood thin medication 10 . Oral temperature &gt; 100˚F baseline 11 . Febrile illness use antibiotic 4 week study commencement ; 12 . Planned surgery procedure study period , operate 4 week study commencement 13 . Pregnant plan become pregnant within 6 month 14 . Regular use antiinflammatory medication ( aspirin , ibuprofen , naproxen ) 15 . Known allergy adverse effect follow naltrexone naloxone administration 16 . Opioid use ( selfreported positive urine test ) 17 . Significant psychological comorbidity discretion investigator compromise study integrity and/or baseline HADS depression subscale score ≥16 18 . Current litigation worker 's compensation claim 19 . Current participation another treatment trial 20 . Vaccinated 4 week study commencement ( vaccination study period allow long drug administer least 4 week prior study blood draw ) .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>